1. Home
  2. GKOS vs PSN Comparison

GKOS vs PSN Comparison

Compare GKOS & PSN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Glaukos Corporation

GKOS

Glaukos Corporation

N/A

Current Price

$97.97

Market Cap

6.9B

Sector

Health Care

ML Signal

N/A

Logo Parsons Corporation

PSN

Parsons Corporation

N/A

Current Price

$57.42

Market Cap

7.7B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
GKOS
PSN
Founded
1998
1944
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
7.7B
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
GKOS
PSN
Price
$97.97
$57.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
13
Target Price
$133.07
$83.50
AVG Volume (30 Days)
679.7K
1.3M
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
3.77
EPS
N/A
2.20
Revenue
$507,442,000.00
$6,364,245,000.00
Revenue This Year
$23.39
$6.08
Revenue Next Year
$27.46
$7.63
P/E Ratio
N/A
$26.73
Revenue Growth
32.33
N/A
52 Week Low
$73.16
$56.27
52 Week High
$130.23
$89.50

Technical Indicators

Market Signals
Indicator
GKOS
PSN
Relative Strength Index (RSI) 29.36 30.05
Support Level $81.54 N/A
Resistance Level $102.19 $68.13
Average True Range (ATR) 3.58 1.77
MACD -2.20 -0.75
Stochastic Oscillator 0.38 0.56

Price Performance

Historical Comparison
GKOS
PSN

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About PSN Parsons Corporation

Parsons Corp is a provider of technology-driven solutions in the defense, intelligence, and critical infrastructure markets. The business activities of the group are carried out through Federal Solutions and Critical Infrastructure segments. The Federal Solutions segment is a high-end service and technology provider to the U.S. government, delivering timely, cost-effective solutions for mission-critical projects, whereas the Critical Infrastructure segment provides integrated design and engineering services for complex physical and digital infrastructure around the globe.

Share on Social Networks: